Search by Drug Name or NDC

    NDC 68180-0285-01 rifabutin 150 mg/1 Details

    rifabutin 150 mg/1

    rifabutin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is RIFABUTIN.

    Product Information

    NDC 68180-0285
    Product ID 68180-285_37e2f25d-c2b3-4d13-b33e-6a9ffafc99ff
    Associated GPIs 09000075000120
    GCN Sequence Number 018766
    GCN Sequence Number Description rifabutin CAPSULE 150 MG ORAL
    HIC3 W2E
    HIC3 Description ANTI-MYCOBACTERIUM AGENTS
    GCN 29810
    HICL Sequence Number 007626
    HICL Sequence Number Description RIFABUTIN
    Brand/Generic Generic
    Proprietary Name rifabutin
    Proprietary Name Suffix n/a
    Non-Proprietary Name rifabutin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name RIFABUTIN
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Rifamycin Antimycobacterial [EPC], Rifamycins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090033
    Listing Certified Through 2024-12-31

    Package

    NDC 68180-0285-01 (68180028501)

    NDC Package Code 68180-285-01
    Billing NDC 68180028501
    Package 100 CAPSULE in 1 BOTTLE (68180-285-01)
    Marketing Start Date 2014-03-26
    NDC Exclude Flag N
    Pricing Information N/A